spacer
home > epc > spring 2018 > early beginnings
PUBLICATIONS
European Pharmaceutical Contractor

Early Beginnings

Moving a promising drug candidate from the laboratory to first-in-human (FIH) trials is a complex, multistage challenge. Coordinating the formulation development steps, manufacturing, and logistics involved requires careful management and planning.

Integrating the process in collaboration with expert vendors offers drug developers an efficient, cost-effective pathway to success in early phase development. Furthermore, experienced contractors can help drug companies avoid the early phase pitfalls that can see projects fail at a later stage.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
1
     

There are no comments in regards to this article.

spacer
Dr Torkel Gren is General Manager at Recipharm Pharmaceutical Development. Torkel holds degrees in pharmacy and business administration, as well a PhD in Pharmaceutics from Uppsala University, Sweden. He has worked in the pharma industry since 1988 and has held a number of scientist and manager positions in Europe and the US. Torkel was lead formulator and co-inventor of Detrol OD/Detrusitol SR. He is a member of the board of the Swedish Pharmaceutical Society.

Anders Millerhovf is CEO at CTC Clinical Trial Consultants. He holds a degree in medical biology from Linköping University, Sweden. Anders has worked in the life sciences industry since 2002 and has been focused on Phase 0-2a projects in various management and director positions. He has been a partner at CTC since 2012.
spacer
Dr Torkel Gren
spacer
spacer
spacer
Anders Millerhovf
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Philadelphia, USA – October 15, 2018. Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced the completion of a dedicated Returns Management facility at its Clinical Services Center of Excellence at Bridgend, UK. PCI provides a full service Returns Management service for clients, providing visibility and accountability in returning investigational drug product from investigational sites at the conclusion of a clinical study. Returning and reconciling Investigational Medicinal Product (IMP) on completion of a study is a critical part of a Clinical trial and can require complex reverse logistics. Trial outcomes can be impacted if Returns are not processed efficiently and precisely.
More info >>

White Papers

The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms

Teknomek Ltd

Teknomek explains why stainless steel is the material of choice for laboratories and hygienic manufacturing.
More info >>

 
Industry Events

4th Annual Genome Editing Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement